ADLYFE, INC.

Basic Information

9430 Key West Avenue, Suite 210
Rockville, MD, 20850

Company Profile

n/a

Additional Details

Field Value
DUNS: 137192840
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 10


  1. Development of novel methods and reagents for surveillence of prion infection

    Amount: $750,000.00

    The prion disease process involves a conformational change in the prion protein that in turn can serve as the basis for an early detection, diagnostic, prognostic and screening assay. The Misfolded P ...

    SBIR Phase II 2007 Department of DefenseArmyDepartment of Defense
  2. Development of a hemostatic wound dressing incorporating lyophilized platelets

    Amount: $0.00

    Blood loss due to uncontrolled hemorrhage is a major contribution to at least 90% of the combat death before reaching the field hospital. The ability to control heavy bleeding in the injured soldier i ...

    SBIR Phase I 2005 Department of DefenseArmyDepartment of Defense
  3. Development of a hemostatic wound dressing incorporating lyophilized platelets

    Amount: $750,000.00

    Blood loss due to uncontrolled hemorrhage is a major contribution to at least 90% of the combat death before reaching the field hospital. The ability to control heavy bleeding in the injured soldier i ...

    SBIR Phase II 2005 Department of DefenseArmyDepartment of Defense
  4. Development of novel methods and reagents for surveillence of prion infection

    Amount: $100,000.00

    Adlyfe Inc. has developed a highly sensitive fluorescence based test, called the Misfolded Protein Diagnostic (MPD) Assay, for the misfolded prion protein associated with infectivity. The femtomolar ...

    SBIR Phase I 2005 Department of DefenseArmyDepartment of Defense
  5. Development of a hemostatic wound dressing incorporating lyophilized platelets

    Amount: $100,000.00

    The main goal of this proposal is to develop stabilized freeze-dried Yucatan pig platelets that will retain the majority of platelet biological properties, but can be stored in the dry state for years ...

    SBIR Phase I 2005 Department of DefenseArmyDepartment of Defense
  6. Stabilized Platelets for Advanced Wound Healing

    Amount: $99,076.00

    DESCRIPTION (provided by applicant): The overall goal of this Phase I proposal is to determine the resiliency of platelets during the stabilization process to co-accumulate secondary compounds to en ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government